In case you missed it, our 2025 review on the BCL-2 protein family summarises the field from discovery to drug development
The BCL-2 protein family: from discovery to drug development
Read here: rdcu.be/e6MVA
In case you missed it, our 2025 review on the BCL-2 protein family summarises the field from discovery to drug development
The BCL-2 protein family: from discovery to drug development
Read here: rdcu.be/e6MVA
What drugs are safe during pregnancy? Thereβs a shocking lack of data www.nature.com/articles/d41...
Why ADHD goes undiagnosed in girls www.nature.com/articles/d41...
I am excited to share our latest publication in @narjournal.bsky.social π€© Thanks to everyone who made this possible @mrc-tu.bsky.social
Functional characterisation of tumour suppressor PDCD4 reveals previously undisclosed role in the control of cell adhesion url: academic.oup.com/nar/article/...
Only Humans can add:
Contextual understanding
Ethical judgment
Empathy and tone
www.springernature.com/gp/advancing...
Polysome sorting controls mRNA localization and protein fate: Trends in Cell Biology www.cell.com/trends/cell-...
βNAR Breakthrough!β
𧬠New study shows that small activating RNAs can boost MBNL1 expression in #myotonicdystrophy cells, restoring splicing balance. This highlights #RNAactivation (RNAa) as a promising #therapeutic strategy for this #raredisease.
π doi.org/10.1093/nar/...
#NARBreakthrough
βHuman judgement first, and technology in supportβ blogs.lse.ac.uk/impactofsoci...
Age as a risk factor of autoimmunity.
A Perspective article, published in Nature Aging, discusses whether aging predisposes to autoimmunity, arguing that disease progression in the autoimmune vasculitis giant cell arteritis is driven by age-inappropriate sustenance of immune competence. go.nature.com/3UvrpvBπ π§ͺ